Grail Company
Grail develops a pan-cancer screening test designed to detect cancers at an early stage.
Investors
Number Of Exists:
501-1000
Industry:
Bioengineering
Funding Status:
M&A
Estimated Revenue:
$50M to $100M
Headquarters:
Menlo Park, California, United States
Technology:
Сancer Diagnostics
Investor Type:
N/A
Founded Date:
2016
Employee Number:
201-500
Investment Stage:
N/A